• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    110 Biggest Movers From Friday

    5/16/22 5:23:29 AM ET
    $AFI
    $AFRM
    $AI
    $ALT
    Building Products
    Capital Goods
    Finance: Consumer Services
    Finance
    Get the next $AFI alert in real time by email

    Gainers

    • ShiftPixy, Inc. (NASDAQ:PIXY) shares jumped 154.9% to close at $0.51. ShiftPixy reported board approval special dividend to shareholders in form of common shares of Industrial Human Capital.
    • PolarityTE, Inc. (NASDAQ:PTE) gained 44.5% to settle at $0.2117. The U.S. Food and Drug Administration (FDA) granted a Regenerative Medicine Advanced Therapy (RMAT) designation to PolarityTE’s (NASDAQ:PTE) SkinTE under the its open investigational new drug application (IND).
    • Veru Inc. (NASDAQ:VERU) shares surged 44% to close at $13.00 on Friday after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) jumped 42.8% to settle at $0.23. The company recently reported a net loss of $13.8 million for the three months ended March 31, 2022.
    • View, Inc. (NASDAQ:VIEW) gained 38.7% to close at $0.6501. View recently in a 10-Q filing said it does not currently have adequate financial resources to fund its forecasted operating costs and will look to raise capital.
    • Inotiv, Inc. (NASDAQ:NOTV) climbed 38.4% to close at $16.55 after the company reported better-than-expected Q2 results.
    • Amyris, Inc. (NASDAQ:AMRS) gained 37.2% to close at $2.36. Amyris recently reported a drop in Q1 EPS and sales.
    • Leap Therapeutics, Inc. (NASDAQ:LPTX) jumped 34.6% to settle at $1.31. Leap Therapeutics posted a Q1 net loss of $10.4 million.
    • Expensify, Inc. (NASDAQ:EXFY) climbed 34.5% to settle at $20.49 after the company posted Q1 results and announced a $50 million buyback program.
    • Molecular Data Inc. (NASDAQ:MKD) gained 34.5% to close at $0.1224.
    • Duolingo, Inc. (NASDAQ:DUOL) jumped 34% to settle at $89.77 after the company reported better-than-expected Q1 EPS and sales results.
    • Genocea Biosciences, Inc. (NASDAQ:GNCA) gained 33.9% to close at $0.2250.
    • A2Z Smart Technologies Corp. (NASDAQ:AZ) rose 33.8% to settle at $4.63.
    • Lightspeed Commerce Inc. (NYSE:LSPD) surged 32.2% to close at $21.37.
    • PagSeguro Digital Ltd. (NYSE:PAGS) gained 31.8% to close at $13.47.
    • Payoneer Global Inc. (NASDAQ:PAYO) rose 31.4% to close at $4.73 after the company reported better-than-expected Q1 EPS and sales results and issued FY22 sales guidance above analyst estimates.
    • Affirm Holdings, Inc. (NASDAQ:AFRM) shares jumped 31.4% to settle at $23.71 after the company reported upbeat results for its third quarter and raised its revenue forecast for the fiscal year. The company also announced a multi-year extension of its partnership in the U.S. with Shopify.
    • Hippo Holdings Inc. (NASDAQ:HIPO) rose 30.7% to settle at $1.62 following Q1 results.
    • Vaccitech plc (NASDAQ:VACC) gained 30.1% to close at $4.02. HC Wainwright & Co. maintained Vaccitech with a Buy and lowered the price target from $23 to $22.
    • indie Semiconductor, Inc. (NASDAQ:INDI) rose 28.5% to close at $6.94 after the company reported better-than-expected Q1 EPS and sales results.
    • Viridian Therapeutics, Inc. (NASDAQ:VRDN) gained 28% to close at $13.52 following earnings.
    • PLx Pharma Inc. (NASDAQ:PLXP) rose 27.6% to settle at $2.59 following narrower-than-expected Q1 loss.
    • Celularity Inc. (NASDAQ:CELU) climbed 27.2% to close at $7.34.
    • Kaival Brands Innovations Group, Inc. (NASDAQ:KAVL) rose 25.3% to settle at $0.9099.
    • Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) jumped 25% to close at $1.85.
    • Robinhood Markets, Inc. (NASDAQ:HOOD) shares gained 24.9% to close at $10.69 after a 13D filing showed Samuel Bankman-Fried, founder and CEO of FTX crypto exchange, disclosed a 7.6% stake in the company.
    • Stryve Foods, Inc. (NASDAQ:SNAX) rose 24.7% to settle at $1.11 after the company reported better-than-expected Q1 EPS and sales results.
    • Momentus Inc. (NASDAQ:MNTS) jumped 24.7% to close at $2.93. Momentus recently posted a Q1 loss of $0.34 per share.
    • KLX Energy Services Holdings, Inc. (NASDAQ:KLXE) gained 24.7% to close at $4.95. KLX Energy Services recently posted Q1 sales of $152.30 million.
    • Beyond Meat, Inc. (NASDAQ:BYND) climbed 24.6% to close at $31.24. Beyond Meat recently reported worse-than-expected Q1 EPS and sales results.
    • Chembio Diagnostics, Inc. (NASDAQ:CEMI) gained 24.4% to settle at $0.5593. Chembio Diagnostics recently posted a Q1 loss of $0.29 per share.
    • EQRx, Inc. (NASDAQ:EQRX) gained 24.2% to close at $4.11 following Q1 results.
    • Poshmark, Inc. (NASDAQ:POSH) jumped 23.8% to settle at $12.04 following Q1 results.
    • Aurora Mobile Limited (NASDAQ:JG) gained 23.8% to close at $1.04.
    • LightPath Technologies, Inc. (NASDAQ:LPTH) rose 23.7% to settle at $1.62 after reporting Q3 results.
    • IN8bio, Inc. (NASDAQ:INAB) jumped 23.6% to close at $2.78. IN8bio posted a Q1 loss of $0.33 per share.
    • Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) gained 23.2% to close at $12.47.
    • CleanSpark, Inc. (NASDAQ:CLSK) climbed 23% to close at $6.32. Cleanspark recently posted Q2 sales of $41.60 million.
    • Outset Medical, Inc. (NASDAQ:OM) gained 23% to settle at $24.86.
    • Sea Limited (NYSE:SE) surged 22.7% to close at $75.40.
    • Asana, Inc. (NYSE:ASAN) jumped 22.7% to settle at $24.37.
    • Dave Inc. (NASDAQ:DAVE) gained 22.7% to close at $2.87 following Q1 results.
    • Zai Lab Limited (NASDAQ:ZLAB) rose 22.7% to settle at $33.22. Zai Lab recently reported better-than-expected Q1 EPS and sales results.
    • Synchronoss Technologies, Inc. (NASDAQ:SNCR) jumped 22.7% to settle at $1.46.
    • Venus Concept Inc. (NASDAQ:VERO) gained 22.3% to settle at $0.8562.
    • Roivant Sciences Ltd. (NASDAQ:ROIV) jumped 23.1% to close at $3.46.
    • Nutex Health, Inc. (NASDAQ:NUTX) surged 22.4% to settle at $6.12.
    • Alpha Tau Medical Ltd. (NASDAQ:DRTS) rose 22.2% to close at $7.00.
    • C3.ai, Inc. (NYSE:AI) climbed 22.1% to close at $17.78.
    • Porch Group, Inc. (NASDAQ:PRCH) gained 22.1% to settle at $4.64. The company recently posted upbeat quarterly sales.
    • Doma Holdings Inc. (NYSE:DOMA) surged 22% to close at $1.83.
    • Compass, Inc. (NYSE:COMP) jumped 21.9% to close at $5.45. Compass posted a Q1 loss of $0.45 per share.
    • Galera Therapeutics, Inc. (NASDAQ:GRTX) gained 21.8% to settle at $1.51. Galera Therapeutics recently announced topline results from Phase 2a AESOP trial of avasopasem for severe acute radiation-induced esophagitis in lung cancer patients receiving concurrent chemoradiotherapy.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) rose 21.7% to close at $0.4475.
    • HUYA Inc. (NYSE:HUYA) gained 21.6% to settle at $3.89.
    • Arrival (NASDAQ:ARVL) jumped 21.3% to close at $1.94.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) gained 21.2% to close at $2.46. Faraday Future posted a FY22 loss of $2.21 per share.
    • Dynavax Technologies Corporation (NASDAQ:DVAX) climbed 21.1% to close at $9.60. Dynavax Technologies is set to join S&P SmallCap 600.
    • ESS Tech, Inc. (NYSE:GWH) gained 21% to close at $4.95. ESS Tech posted a Q1 loss of $0.04 per share.
    • FingerMotion, Inc. (NASDAQ:FNGR) jumped 21% to settle at $1.50.
    • Field Trip Health Ltd. (NASDAQ:FTRP) gained 20.9% to close at $0.9430.
    • Oatly Group AB (NASDAQ:OTLY) climbed 20.8% to close at $3.71.
    • Blend Labs, Inc. (NASDAQ:BLND) rose 20.7% to close at $3.68 after the company reported better-than-expected Q1 sales results and reaffirmed FY22 sales guidance.
    • Embark Technology, Inc. (NASDAQ:EMBK) gained 20.6% to settle at $2.34.
    • 1Life Healthcare, Inc. (NASDAQ:ONEM) rose 20.6% to close at $8.37.
    • Altimmune, Inc. (NASDAQ:ALT) gained 20.6% to settle at $5.16. Altimmune posted a Q1 loss of $0.44 per share.
    • DLocal Limited (NASDAQ:DLO) jumped 20.5% to close at $20.77.
    • Joby Aviation, Inc. (NASDAQ:JOBY) rose 20.3% to close at $5.33 after the company reported better-than-expected Q1 EPS results.
    • WeWork Inc. (NYSE:WE) jumped 20.1% to close at $6.76. WeWork posted a Q1 loss of $0.57 per share.
    • My Size, Inc. (NASDAQ:MYSZ) rose 19.9% to settle at $0.24 after the company reported Q1 EPS and sales results were up year over year.
    • Stem, Inc. (NYSE:STEM) gained 19.7% to close at $7.76.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) jumped 19.7% to settle at $0.8492. Mobiquity Technologies won a contract with KNEEDLESS as its data, programmatic advertising provider.
    • Immersion Corporation (NASDAQ:IMMR) surged 19.6% to close at $5.31 following upbeat quarterly earnings.
    • MicroStrategy Incorporated (NASDAQ:MSTR) gained 19.5% to settle at $204.57.
    • SomaLogic, Inc. (NASDAQ:SLGC) gained 19.1% to close at $5.42 after reporting Q1 results.
    • Silvergate Capital Corporation (NYSE:SI) jumped 19.1% to settle at $75.87.
    • TScan Therapeutics, Inc. (NASDAQ:TCRX) climbed 18.6% to settle at $2.49.
    • Laird Superfood, Inc. (NYSE:LSF) climbed 18.6% to close at $2.61following strong quarterly sales.
    • Bill.com Holdings, Inc. (NASDAQ:BILL) climbed 18.6% to close at $118.54.
    • Lightwave Logic, Inc. (NASDAQ:LWLG) gained 17.1% to close at $8.12.
    • Cloudflare, Inc. (NYSE:NET) gained 17% to settle at $66.38.
    • Ryder System, Inc. (NYSE:R) gained 17% to close at $83.65. Ryder 13D Filing from HG Vora showed the company issued proposal to acquire all shares of company’s common stock at $86 per share.
    • Alpha and Omega Semiconductor Limited (NASDAQ:AOSL) gained 16.7% to close at $38.75 after it was announced the company will replace Mimecast in the S&P SmallCap 600.
    • The RealReal, Inc. (NASDAQ:REAL) climbed 16.5% to settle at $3.75 after dipping around 6% on Thursday.
    • Molecular Partners AG (NASDAQ:MOLN) gained 15.2% to close at $6.90 Molecular Partners recently said its partner Novartis expects the FDA may require additional clinical data for the Emergency Use Application for ensovibep.
    • CTI BioPharma Corp. (NASDAQ:CTIC) rose 14.8% to close at $4.20 following upbeat quarterly results.
    • Array Technologies, Inc. (NASDAQ:ARRY) climbed 14.2% to close at $7.08. Array Technologies recently reported Q1 earnings results and issued FY22 adjusted EPS guidance below estimates.
    • Graphite Bio, Inc. (NASDAQ:GRPH) gained 14% to close at $2.60 after the company posted a narrower Q1 loss.
    • McEwen Mining Inc. (NYSE:MUX) gained 9.1% to close at $0.5030. McEwen Mining recently posted a Q1 loss of $0.04 per share.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) gained 8.7% to close at $0.2337 after gaining around 8% on Thursday.

     

    Losers

    • LiqTech International, Inc. (NASDAQ:LIQT) shares tumbled 45.4% to close at $0.50 on Friday after the company priced its public offering of common stock and pre-funded warrants.
    • Actelis Networks Inc. (NASDAQ:ASNS) shares dipped 40% to close at $2.40 after the company priced its IPO at $4 per share.
    • Jupai Holdings Limited (NYSE:JP) dropped 36.4% to close at $0.4767.
    • Brilliant Earth Group, Inc. (NASDAQ:BRLT) fell 33.6% to close at $4.48 after the company reported issued Q2 and FY22 net sales guidance below analyst estimates.
    • Tenon Medical, Inc. (NASDAQ:TNON) fell 26.4% to close at $6.52.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) dropped 25.4% to close at $0.70. Vallon Pharmaceuticals announced a $3.9 million registered direct offering.
    • FIGS, Inc. (NYSE:FIGS) fell 25% to close at $9.64 after the company reported worse-than-expected Q1 adjusted EPS and sales results and cut FY22 sales guidance to below analyst estimates.
    • Armstrong Flooring, Inc. (NYSE:AFI) dipped 18.7% to settle at $0.3250.
    • Direct Digital Holdings, Inc. (NASDAQ:DRCT) fell 18.4% to close at $2.00. Direct Digital posted a Q1 loss of $0.09 per share.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) dropped 16.7% to close at $0.4404.
    • Sky Harbour Group Corporation (NYSE:SKYH) fell 16.2% to close at $7.23 after reporting Q1 results.
    • Enfusion, Inc. (NYSE:ENFN) fell 16% to close at $8.40 after the company reported worse-than-expected Q1 EPS results.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) dropped 15.6% to close at $5.66 following Q1 earnings.
    • Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) shares fell 15.4% to close at $0.1879. Salarius Pharmaceuticals posted a Q1 loss of $0.13 per share.
    • Xponential Fitness, Inc. (NYSE:XPOF) fell 13.6% to close at $14.37 after reporting a loss for the first quarter.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) fell 12.3% to close at $0.2153. Regulus Therapeutics posted a Q1 loss of $0.05 per share.
    • Kiromic BioPharma, Inc. (NASDAQ:KRBP) dropped 11.6% to settle at $0.3339. Kiromic BioPharma recently announced it will submit an amended Investigational New Drug Application for its first oncology cell therapy candidate Procel directly to the FDA in the second half of 2022.
    • Stealth BioTherapeutics Corp (NASDAQ:MITO) fell 9.7% to close at $0.2258. Stealth BioTherapeutics shares jumped around 32% on Thursday after the company announced the FDA has granted Orphan Drug Designation for elamipretide for the treatment duchenne muscular dystrophy.
    • Twitter, Inc. (NYSE:TWTR) fell 9.7% to close at $40.72. After running the hard mile to mobilize finances for his Twitter buy, Elon Musk said early Friday the deal is on hold.
    • Digimarc Corporation (NASDAQ:DMRC) fell 9.4% to close at $18.31 following weak quarterly results.
    Get the next $AFI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFI
    $AFRM
    $AI
    $ALT

    CompanyDatePrice TargetRatingAnalyst
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Buy → Hold
    Truist
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Buy → Neutral
    BofA Securities
    Xponential Fitness Inc.
    $XPOF
    2/27/2026$7.00Buy → Neutral
    Roth Capital
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Sector Outperform → Sector Perform
    Scotiabank
    Duolingo Inc.
    $DUOL
    2/27/2026$95.00Overweight → Neutral
    Analyst
    Duolingo Inc.
    $DUOL
    2/27/2026$114.00Outperform → In-line
    Evercore ISI
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Overweight → Equal-Weight
    Morgan Stanley
    Duolingo Inc.
    $DUOL
    2/27/2026$101.00Buy → Neutral
    Citigroup
    More analyst ratings

    $AFI
    $AFRM
    $AI
    $ALT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Duolingo downgraded by Truist with a new price target

    Truist downgraded Duolingo from Buy to Hold and set a new price target of $100.00

    2/27/26 12:55:49 PM ET
    $DUOL
    Computer Software: Prepackaged Software
    Technology

    Duolingo downgraded by BofA Securities with a new price target

    BofA Securities downgraded Duolingo from Buy to Neutral and set a new price target of $100.00

    2/27/26 10:22:22 AM ET
    $DUOL
    Computer Software: Prepackaged Software
    Technology

    Xponential Fitness downgraded by Roth Capital with a new price target

    Roth Capital downgraded Xponential Fitness from Buy to Neutral and set a new price target of $7.00

    2/27/26 8:34:02 AM ET
    $XPOF
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $AFI
    $AFRM
    $AI
    $ALT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Spinnaker Ostergaard Torben sold $18,266 worth of shares (600 units at $30.44), decreasing direct ownership by 1% to 46,094 units (SEC Form 4)

    4 - Hippo Holdings Inc. (0001828105) (Issuer)

    2/27/26 4:58:59 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    Director North Run Strategic Opportunities Fund I, Lp sold $3,655,121 worth of shares (300,092 units at $12.18) (SEC Form 4)

    4 - LIGHTPATH TECHNOLOGIES INC (0000889971) (Issuer)

    2/27/26 4:44:08 PM ET
    $LPTH
    Semiconductors
    Technology

    SEC Form 4 filed by Chief Scientific Officer Roberts M Scot

    4 - Altimmune, Inc. (0001326190) (Issuer)

    2/27/26 4:10:07 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $AFRM
    $AI
    $ALT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Asana to Present at Upcoming Investor Events

    Asana, Inc. (NYSE:ASAN)(LTSE: ASAN), a leading work management platform for human and AI collaboration, today announced that Asana's executives will present at the following investor events: KBCM Emerging Technology Summit on March 3, 2026 at 9:00 a.m. PT / 12:00 p.m. ET The Citizens Technology Conference on March 3, 2026 at 1:00 p.m. PT / 4:00 p.m. ET Morgan Stanley Technology, Media & Telecom Conference on March 4, 2026 at 10:45 a.m. PT / 1:45 p.m. ET A live webcast will be available on Asana's website at https://investors.asana.com. About Asana Asana is a leading work management platform for human and AI collaboration. Over 170,000 customers like Accenture, Amazon, Anthro

    2/27/26 4:05:00 PM ET
    $ASAN
    Computer Software: Prepackaged Software
    Technology

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    LiqTech International Announces Financial Results for Fourth Quarter and Full Year 2025

    BALLERUP, Denmark, Feb. 27, 2026 (GLOBE NEWSWIRE) -- LiqTech International, Inc. (NASDAQ:LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announces its financial results for the fourth quarter and fiscal year 2025 for the period ended December 31, 2025. Recent Financial Highlights FY 2025 revenue of $16.5 million, a 13% increase from $14.6 million in FY 2024. Q4 2025 revenue of $3.1 million, compared to $3.4 million in Q4 2024, an 8% decrease.FY 2025 net loss of $(8.6) million compared to $(10.3) million in FY 2024. Q4 2025 net loss of $(2.6) million compared to $(3.0) million in Q4 2024.FY 2025 Adjusted EBITDA

    2/27/26 8:00:00 AM ET
    $LIQT
    Industrial Machinery/Components
    Technology

    $AFI
    $AFRM
    $AI
    $ALT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Zeltser Guy bought $4,808 worth of shares (665 units at $7.23) and covered exercise/tax liability with 4,483 shares, decreasing direct ownership by 6% to 65,042 units (SEC Form 4)

    4 - Hippo Holdings Inc. (0001828105) (Issuer)

    2/18/26 7:02:59 PM ET
    $HIPO
    Property-Casualty Insurers
    Finance

    Director Pisano Wayne bought $20,410 worth of shares (5,000 units at $4.08), increasing direct ownership by 59% to 13,498 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    1/9/26 4:10:05 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Sohn Catherine A. bought $2,118 worth of shares (500 units at $4.24), increasing direct ownership by 50% to 1,500 units (SEC Form 4)

    4 - Altimmune, Inc. (0001326190) (Issuer)

    1/5/26 4:05:39 PM ET
    $ALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $AFRM
    $AI
    $ALT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for OPVEE issued to OPIANT PHARMACEUTICALS INC

    Submission status for OPIANT PHARMACEUTICALS INC's drug OPVEE (ORIG-1) with active ingredient NALMEFENE has changed to 'Approval' on 05/22/2023. Application Category: NDA, Application Number: 217470, Application Classification: Type 3 - New Dosage Form

    5/24/23 11:39:07 AM ET
    $OPNT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    May 22, 2023 - FDA Approves Prescription Nasal Spray to Reverse Opioid Overdose

    For Immediate Release: May 22, 2023 Today, the U.S. Food and Drug Administration approved Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older. This is the first FDA approval of nalmefene hydrochloride nasal spray for health care and community use. “The agency continues to advance the FDA

    5/22/23 4:58:14 PM ET
    $OPNT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OPVEE (nalmefene) issued to OPIANT PHARMACEUTICALS INC

    Submission status for OPIANT PHARMACEUTICALS INC's drug OPVEE (nalmefene) (ORIG-1) with active ingredient OPVEE (nalmefene) has changed to 'Approval' on 05/22/2023. Application Category: NDA, Application Number: 217470, Application Classification: Type 3 - New Dosage Form

    5/22/23 4:51:13 PM ET
    $OPNT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AFI
    $AFRM
    $AI
    $ALT
    SEC Filings

    View All

    LightPath Technologies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - LIGHTPATH TECHNOLOGIES INC (0000889971) (Filer)

    2/27/26 4:55:45 PM ET
    $LPTH
    Semiconductors
    Technology

    SEC Form S-8 filed by Compass Inc.

    S-8 - Compass, Inc. (0001563190) (Filer)

    2/27/26 4:53:13 PM ET
    $COMP
    EDP Services
    Technology

    SEC Form 10-K filed by Compass Inc.

    10-K - Compass, Inc. (0001563190) (Filer)

    2/27/26 4:51:19 PM ET
    $COMP
    EDP Services
    Technology

    $AFI
    $AFRM
    $AI
    $ALT
    Financials

    Live finance-specific insights

    View All

    Blend to Announce Fourth Quarter 2025 Financial Results on March 10, 2026

    Blend Labs, Inc. (NYSE:BLND), a leading digital origination platform, today announced that the Company's fourth quarter 2025 financial results will be released after market close on Tuesday, March 10, 2026. The Company will host a conference call to discuss its results at 1:30 p.m. PT / 4:30 p.m. ET the same day. A link to the live call can be accessed at the Company's Investor Relations website at investor.blend.com, along with the Company's earnings press release, financial information, and slide presentation. Following the call, a replay will be available at the same website. About Blend Blend Labs Inc., (NYSE:BLND) is a leading origination platform for digital banking solutions. F

    2/27/26 4:00:00 PM ET
    $BLND
    Computer Software: Programming Data Processing
    Technology

    LiqTech International Announces Financial Results for Fourth Quarter and Full Year 2025

    BALLERUP, Denmark, Feb. 27, 2026 (GLOBE NEWSWIRE) -- LiqTech International, Inc. (NASDAQ:LIQT) ("LiqTech"), a clean technology company that manufactures and markets highly specialized filtration technologies, today announces its financial results for the fourth quarter and fiscal year 2025 for the period ended December 31, 2025. Recent Financial Highlights FY 2025 revenue of $16.5 million, a 13% increase from $14.6 million in FY 2024. Q4 2025 revenue of $3.1 million, compared to $3.4 million in Q4 2024, an 8% decrease.FY 2025 net loss of $(8.6) million compared to $(10.3) million in FY 2024. Q4 2025 net loss of $(2.6) million compared to $(3.0) million in Q4 2024.FY 2025 Adjusted EBITDA

    2/27/26 8:00:00 AM ET
    $LIQT
    Industrial Machinery/Components
    Technology

    Dave to Report Fourth Quarter and Full Year 2025 Results and Participate in Upcoming Investor Conferences

    LOS ANGELES, CA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company") (NASDAQ:DAVE), one of the nation's leading neobanks, today announced its participation in two upcoming investor conferences following the Company's fourth quarter and full year 2025 earnings conference call on Monday, March 2, 2026, at 5:00 p.m. Eastern time. The earnings conference call and investor conference details are as follows: Earnings Conference Call Date: Monday, March 2, 2026Time: 5:00 p.m. Eastern timeConference Call Registration: linkWebcast: link The conference call will also be available for replay in the Events section of the Company's website, along with the transcript, at https://in

    2/26/26 4:15:00 PM ET
    $DAVE
    Finance: Consumer Services
    Finance

    $AFI
    $AFRM
    $AI
    $ALT
    Leadership Updates

    Live Leadership Updates

    View All

    ESS Appoints Randall Selesky as Chief Commercial Officer to Accelerate Global Growth

    Veteran Energy Storage Commercial Leader to Drive Global Commercial Execution as ESS Strengthens Leadership Team and Scales Deployments ESS Tech, Inc. (NYSE:GWH) ("ESS" or the "Company"), a leading innovator in long-duration energy storage solutions, today announced that Randall "Randy" Selesky has joined the company as Chief Commercial Officer (CCO). In this role, Selesky will lead global commercial strategy, sales, marketing, product management, and business development initiatives as ESS advances commercialization and scales deployment of its long-duration energy storage solutions worldwide. Selesky joins ESS with more than 20 years of leadership in the energy sector, including more

    2/19/26 8:40:00 AM ET
    $GWH
    Industrial Machinery/Components
    Miscellaneous

    LiqTech International Appoints Bob Wowk to Board of Directors

    BALLERUP, Denmark, Feb. 18, 2026 (GLOBE NEWSWIRE) -- LiqTech International, Inc. (NASDAQ:LIQT), a leading clean technology company specializing in advanced filtration systems, today announced the appointment of Bob Wowk to its Board of Directors, effective immediately. Wowk has over 30 years of experience as a finance and business development executive principally in the industrial gas business and renewable energy sectors. Wowk spent over 20 years with Linde, Gulf Cryo and Air Products in global senior financial roles before transitioning to CFO roles over the last 10 years with small and mid-size companies involved in solar, waste-to-energy, lithium and H2 including sPower/AES, EnergyX

    2/18/26 9:00:00 AM ET
    $LIQT
    Industrial Machinery/Components
    Technology

    Employ Inc. Appoints Jerry Jao as CEO

    DENVER, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Employ Inc., a leading provider of people-first, intelligent hiring solutions across JazzHR, Lever, and Jobvite, today announced the appointment of Jerry Jao as CEO. Jao is a successful serial entrepreneur who founded three businesses, including the AI-powered marketing and personalization SaaS company ReSci (Retention Science), acquired by Constant Contact in 2020. During his executive career, he first encountered Employ as a Lever customer and spent six years using the platform, gaining firsthand insight into how its innovation helps hiring managers stay organized and save time across the hiring process. Jao shared, "Hiring has never needed to

    2/18/26 8:00:00 AM ET
    $FIGS
    Apparel
    Consumer Discretionary

    $AFI
    $AFRM
    $AI
    $ALT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by LightPath Technologies Inc.

    SC 13G/A - LIGHTPATH TECHNOLOGIES INC (0000889971) (Subject)

    12/13/24 3:18:07 PM ET
    $LPTH
    Semiconductors
    Technology